Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4864385
Max Phase: Preclinical
Molecular Formula: C41H55N2O11P
Molecular Weight: 782.87
Molecule Type: Unknown
Associated Items:
ID: ALA4864385
Max Phase: Preclinical
Molecular Formula: C41H55N2O11P
Molecular Weight: 782.87
Molecule Type: Unknown
Associated Items:
Canonical SMILES: CCOP(=O)(/C=C/C(NC(=O)[C@@H]1C[C@@H](O[C@H]2O[C@@H]3O[C@@]4(C)CC[C@H]5[C@H](C)CC[C@@H]([C@H]2C)[C@@]35OO4)CN1C(=O)OCc1ccccc1)c1ccccc1)OCC
Standard InChI: InChI=1S/C41H55N2O11P/c1-6-48-55(46,49-7-2)23-21-34(30-16-12-9-13-17-30)42-36(44)35-24-31(25-43(35)39(45)47-26-29-14-10-8-11-15-29)50-37-28(4)33-19-18-27(3)32-20-22-40(5)52-38(51-37)41(32,33)54-53-40/h8-17,21,23,27-28,31-35,37-38H,6-7,18-20,22,24-26H2,1-5H3,(H,42,44)/b23-21+/t27-,28-,31-,32+,33+,34?,35+,37+,38-,40-,41-/m1/s1
Standard InChI Key: BGYPRGCIFNUKKP-DFXQHAEPSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 782.87 | Molecular Weight (Monoisotopic): 782.3543 | AlogP: 7.63 | #Rotatable Bonds: 13 |
Polar Surface Area: 140.32 | Molecular Species: NEUTRAL | HBA: 11 | HBD: 1 |
#RO5 Violations: 3 | HBA (Lipinski): 13 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 12.72 | CX Basic pKa: | CX LogP: 6.63 | CX LogD: 6.63 |
Aromatic Rings: 2 | Heavy Atoms: 55 | QED Weighted: 0.16 | Np Likeness Score: 1.30 |
1. Aratikatla EK, Kalamuddin M, Rana KC, Datta G, Asad M, Sundararaman S, Malhotra P, Mohmmed A, Bhattacharya AK.. (2021) Combating multi-drug resistant malaria parasite by inhibiting falcipain-2 and heme-polymerization: Artemisinin-peptidyl vinyl phosphonate hybrid molecules as new antimalarials., 220 [PMID:33901900] [10.1016/j.ejmech.2021.113454] |
Source(1):